[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334246-105":59,"doc-detail-334246-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","insulin-like-growth-factor-binding-protein-6-modulates-proliferative-antagonism-in-response-to-progesterone-in-breast-cancer","Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer","","Breast cancer progression is linked to the insulin-like growth factor (IGF) system, regulated by six IGF binding proteins. This study focuses on IGFBP-6 and its role in hormone receptor positive breast cancer, where survival analysis associates higher IGFBP-6 with improved outcomes in progesterone receptor positive cases. Progesterone induces IGFBP-6 in T47D cells, and IGFBP-6 knockdown reduces progesterone-driven proliferative antagonism and lowers PR-A/PR-B protein levels while altering downstream cell-cycle regulators.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/insulin-like-growth-factor-binding-protein-6-modulates-proliferative-antagonism-in-response-to-progesterone-in-breast-cancer/334246/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/insulin-like-growth-factor-binding-protein-6-modulates-proliferative-antagonism-in-response-to-progesterone-in-breast-cancer/334246.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the central role proposed for IGFBP-6 in progesterone signaling in breast cancer?","Question",{"text":112,"@type":113},"IGFBP-6 is described as a regulator of progesterone action, with protective effects requiring progesterone receptor (PR).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does progesterone affect IGFBP-6 in T47D breast cancer cells?",{"text":117,"@type":113},"Progesterone transcriptionally induces IGFBP-6, increasing both intracellular and extracellular IGFBP-6 protein levels.",{"name":119,"@type":110,"acceptedAnswer":120},"What changes occur when IGFBP-6 is knocked down in the presence of progesterone and estradiol?",{"text":121,"@type":113},"IGFBP-6 knockdown reduces proliferative antagonism, decreases protein levels of PR-A and PR-B, and alters progesterone-responsive downstream markers such as p21 and cyclin E2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334246,1790186612,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","TYPE Original Research PUBLISHED 04 December 2024 DOI 10.3389/fendo.2024.1450648  \nOPEN ACCESS  \nEDITED BY  \nVeronica Vella,  \nUniversity of Catania, Italy  \nREVIEWED BY  \nAngelo Canciello, University of Teramo, Italy Adali Pecci,  \nNational Council for Scientiﬁc and Technical Research, Argentina  \n*CORRESPONDENCE  \nKevin D. Houston  \n [khouston@nmsu.edu](khouston@nmsu.edu)  \nRECEIVED 17 June 2024  \nACCEPTED 04 November 2024  \nPUBLISHED 04 December 2024  \nCITATION  \nLariz FJ, Botero PB, Shoffstall I and Houston KD (2024) Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer.  \nFront. Endocrinol. 15:1450648 .  \ndoi: 10.3389/fendo.2024.1450648  \nCOPYRIGHT  \n© 2024 Lariz, Botero, Shoffstall and Houston. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nInsulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer  \nFrancisco J. Lariz, Pacha B. Botero, Isabella Shoffstall and Kevin D. Houston*  \nNew Mexico State University, Department of Chemistry and Biochemistry, Las Cruces, NM, United States  \nBreast cancer is one of the most diagnosed cancers worldwide. The insulin-like growth factor (IGF) system promotes proliferation and survival in breast cancer cells and is regulated by 6 insulin-like growth factor binding proteins (IGFBPs) . The IGFBPs sequester IGFs to prolong their half-life and attenuate binding to insulin-like growth factor 1 receptor (IGF1R) . While IGFBP-6 has been studied in some cancers it has not been studied extensively in hormone receptor positive breast cancer. Survival analysis using available databases indicated that high IGFBP-6 levels improve overall survival in progesterone receptor positive breast cancers. IGFBP-6 is transcriptionally induced by progesterone in T47D breast cancer cells resulting in increased intracellular and extracellular IGFBP-6 protein. Knockdown of IGFBP-6 resulted in reduced proliferative antagonism when estradiol stimulated T47D cells were cotreated with progesterone and protein levels of both progesterone receptor isoforms (PR-A and PR-B) were decreased following knockdown of IGFBP-6 . P21(Cip1/Waf1), which is progesterone responsive, was not induced in response to progesterone following knockdown of IGFBP-6 . Cyclin E2, a cell cycle regulator, is induced by progesterone only when IGFBP-6 is knocked down. Stable overexpression of IGFBP-6 in MCF-7 cells resulted in an increase in Epidermal Growth Factor Receptor (EGFR) and this expression was further enhanced when cells were cotreated with progesterone and estradiol. These results indicate that IGFBP-6 is a regulator of progesterone action, and that PR is required for the observed protective effects of IGFBP-6 in breast cancer.  \nKEYWORDS  \nbreast cancer, progesterone, progesterone receptor, insulin-like growth factor binding protein, steroid hormones  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nInsulin-like growth factor binding protein-6 (IGFBP-6) is oneof a family of six insulin-like growth factor binding proteins (IGFBPs) which regulate the activity of the insulin-like growth factor 1 and 2 (IGF1 and 2) (1–3) . IGFBPs sequester IGFs to attenuate binding to Insulin-like growth factor 1 receptor (IGF1R) which promotes proliferation and survival in breast cancer cells (4) . IGFBPs have their own afﬁnities for the IGFs, however IGFBP-6 has a 20-50-fold binding afﬁnity for IGF-2 over IGF-1 (5) . IGFBP-6 inhibits proliferation in cancer cells which are IGF-2 dependent a","cbCaina9JUMOYnSt","https://ap.wps.com/l/cbCaina9JUMOYnSt","pdf",3158345,12,"English","# Introduction\n## IGF system and IGFBPs in breast cancer\n## Progesterone receptors (PR-A/PR-B) and steroid hormone signaling\n## Rationale for studying IGFBP-6","[{\"question\":\"What is the central role proposed for IGFBP-6 in progesterone signaling in breast cancer?\",\"answer\":\"IGFBP-6 is described as a regulator of progesterone action, with protective effects requiring progesterone receptor (PR).\"},{\"question\":\"How does progesterone affect IGFBP-6 in T47D breast cancer cells?\",\"answer\":\"Progesterone transcriptionally induces IGFBP-6, increasing both intracellular and extracellular IGFBP-6 protein levels.\"},{\"question\":\"What changes occur when IGFBP-6 is knocked down in the presence of progesterone and estradiol?\",\"answer\":\"IGFBP-6 knockdown reduces proliferative antagonism, decreases protein levels of PR-A and PR-B, and alters progesterone-responsive downstream markers such as p21 and cyclin E2.\"}]","Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer | PDF",1790005938]